Search alternatives:
marker decrease » marked decrease (Expand Search), marked increase (Expand Search), markedly decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
small decrease » small increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
marker decrease » marked decrease (Expand Search), marked increase (Expand Search), markedly decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
small decrease » small increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1
-
2
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
3
-
4
-
5
-
6
-
7
Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX
Published 2024“…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”
-
8
Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX
Published 2024“…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”
-
9
-
10
Cohort characteristics.
Published 2025“…The measurement of arterial whole blood redox potential (E<sub>redox</sub>) provides a systemic assessment of the redox state and may serve as a valuable marker for detecting metabolic perturbations during CPB. …”
-
11
-
12
-
13
Supplementary Material for: The current status of tumor markers as biomarkers in the era of immunotherapy for hepatocellular carcinoma: alpha-fetoprotein alone is not sufficient
Published 2025“…Since immune therapy shows a favorable therapeutic efficacy, use of tumor markers as biomarkers for monitoring treatment response is necessary. …”
-
14
-
15
-
16
Image 7_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf
Published 2025“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”
-
17
Image 6_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf
Published 2025“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”
-
18
Image 1_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf
Published 2025“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”
-
19
Image 3_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf
Published 2025“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”
-
20
Image 5_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf
Published 2025“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”